PL2714661T3 - Pochodne kwasu pikolinamidopropanowego przydatne jako antagoniści receptora glukagonu - Google Patents
Pochodne kwasu pikolinamidopropanowego przydatne jako antagoniści receptora glukagonuInfo
- Publication number
- PL2714661T3 PL2714661T3 PL12724507T PL12724507T PL2714661T3 PL 2714661 T3 PL2714661 T3 PL 2714661T3 PL 12724507 T PL12724507 T PL 12724507T PL 12724507 T PL12724507 T PL 12724507T PL 2714661 T3 PL2714661 T3 PL 2714661T3
- Authority
- PL
- Poland
- Prior art keywords
- picolinamido
- acid derivatives
- propanoic acid
- receptor antagonists
- glucagon receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161488842P | 2011-05-23 | 2011-05-23 | |
| PCT/US2012/039171 WO2012162407A1 (en) | 2011-05-23 | 2012-05-23 | Picolinamido - propanoic acid derivatives useful as glucagon receptor antagonists |
| EP12724507.4A EP2714661B1 (en) | 2011-05-23 | 2012-05-23 | Picolinamido - propanoic acid derivatives useful as glucagon receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2714661T3 true PL2714661T3 (pl) | 2016-03-31 |
Family
ID=46178849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12724507T PL2714661T3 (pl) | 2011-05-23 | 2012-05-23 | Pochodne kwasu pikolinamidopropanowego przydatne jako antagoniści receptora glukagonu |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8748624B2 (pl) |
| EP (1) | EP2714661B1 (pl) |
| JP (1) | JP2014515370A (pl) |
| CN (1) | CN103547570A (pl) |
| AU (1) | AU2012258771A1 (pl) |
| CA (1) | CA2837079A1 (pl) |
| DK (1) | DK2714661T3 (pl) |
| ES (1) | ES2557450T3 (pl) |
| ME (1) | ME02228B (pl) |
| MX (1) | MX2013013731A (pl) |
| PL (1) | PL2714661T3 (pl) |
| PT (1) | PT2714661E (pl) |
| WO (1) | WO2012162407A1 (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3205644A1 (en) | 2005-12-29 | 2017-08-16 | Celtaxsys Inc. | Diamine derivatives as inhibitors of leukotriene a4 hydrolase |
| MX2013013732A (es) | 2011-05-23 | 2014-02-27 | Janssen Pharmaceutica Nv | Derivados de bifenilo utiles como antagonistas del receptor de glucagon. |
| EP2968359B1 (en) | 2013-03-12 | 2021-01-20 | Celltaxis, LLC | Methods of inhibiting leukotriene a4 hydrolase |
| BR112015022864A8 (pt) | 2013-03-14 | 2019-11-26 | Celtaxsys Inc | composto, composição farmacêutica e uso dos mesmos |
| AU2014240042C1 (en) | 2013-03-14 | 2019-09-05 | Celltaxis, Llc | Inhibitors of leukotriene A4 hydrolase |
| KR20150131211A (ko) | 2013-03-14 | 2015-11-24 | 켈탁시스, 인코퍼레이티드 | 류코트라이엔 a4 가수분해효소의 저해제 |
| TWI757332B (zh) * | 2016-09-06 | 2022-03-11 | 比利時商健生藥品公司 | 使用作為升糖素受體拮抗劑之吲唑衍生物 |
| TWI763705B (zh) * | 2016-09-06 | 2022-05-11 | 比利時商健生藥品公司 | 可作為升糖素受體拮抗劑之吲哚衍生物 |
| TW201811752A (zh) | 2016-09-06 | 2018-04-01 | 比利時商健生藥品公司 | 用作升糖素受體拮抗劑之吲唑衍生物 |
| CA3102077A1 (en) | 2018-05-31 | 2019-12-05 | Sanjeev AHUJA | Method of reducing pulmonary exacerbations in respiratory disease patients |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0802191A4 (en) | 1995-10-13 | 2001-08-01 | Otsuka Kagaku Kk | PYRAZOLE DERIVATIVES AND INSECTICIDE COMPOSITIONS CONTAINING SUCH DERIVATIVES AS ACTIVE INGREDIENTS |
| ATE307798T1 (de) | 1999-05-17 | 2005-11-15 | Novo Nordisk As | Glucagon antagonisten/inverse agonisten |
| AU2002365622A1 (en) | 2001-12-03 | 2003-06-17 | Novo Nordisk A/S | Novel glucagon antagonists |
| AU2003291959A1 (en) * | 2002-12-20 | 2004-07-14 | Novo Nordisk A/S | Novel glucagon antagonists |
| CA2619101A1 (en) | 2005-08-23 | 2007-03-01 | Irm Llc | Immunosuppressant compounds and compositions |
| PT1951661E (pt) * | 2005-11-17 | 2012-09-19 | Lilly Co Eli | Antagonistas do receptor de glucagon, preparação e utilizações terapêuticas |
| AU2007229850A1 (en) * | 2006-03-23 | 2007-10-04 | Merck & Co., Inc. | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
-
2012
- 2012-05-23 US US13/478,534 patent/US8748624B2/en active Active
- 2012-05-23 PL PL12724507T patent/PL2714661T3/pl unknown
- 2012-05-23 AU AU2012258771A patent/AU2012258771A1/en not_active Abandoned
- 2012-05-23 ME MEP-2015-171A patent/ME02228B/me unknown
- 2012-05-23 JP JP2014512077A patent/JP2014515370A/ja active Pending
- 2012-05-23 ES ES12724507.4T patent/ES2557450T3/es active Active
- 2012-05-23 EP EP12724507.4A patent/EP2714661B1/en active Active
- 2012-05-23 CN CN201280025063.1A patent/CN103547570A/zh active Pending
- 2012-05-23 WO PCT/US2012/039171 patent/WO2012162407A1/en active Application Filing
- 2012-05-23 DK DK12724507.4T patent/DK2714661T3/en active
- 2012-05-23 MX MX2013013731A patent/MX2013013731A/es not_active Application Discontinuation
- 2012-05-23 PT PT127245074T patent/PT2714661E/pt unknown
- 2012-05-23 CA CA2837079A patent/CA2837079A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN103547570A (zh) | 2014-01-29 |
| EP2714661A1 (en) | 2014-04-09 |
| US8748624B2 (en) | 2014-06-10 |
| EP2714661B1 (en) | 2015-09-30 |
| AU2012258771A1 (en) | 2013-11-14 |
| PT2714661E (pt) | 2016-01-22 |
| JP2014515370A (ja) | 2014-06-30 |
| DK2714661T3 (en) | 2015-10-19 |
| CA2837079A1 (en) | 2012-11-29 |
| ES2557450T3 (es) | 2016-01-26 |
| US20120302610A1 (en) | 2012-11-29 |
| ME02228B (me) | 2016-02-20 |
| WO2012162407A1 (en) | 2012-11-29 |
| MX2013013731A (es) | 2014-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1199259A1 (en) | Lysophosphatidic acid receptor antagonists | |
| HK1191008A1 (zh) | 作爲 拮抗劑的 -氨基- -芳基噻唑化合物 | |
| ME02228B (me) | Derivati pikolinamido- propanske kisjelne koji su korisni kao antagonisti receptora glukagona | |
| EP2665707A4 (en) | Mineralocorticoid receptor antagonists | |
| HUE039607T2 (hu) | Progeszteron antagonisták | |
| HK1203938A1 (en) | Novel 2h-indazoles as ep2 receptor antagonists ep2 2h- | |
| HK1192228A1 (zh) | 受體拮抗劑 | |
| HK1199878A1 (en) | Spiroindoline derivatives as gonadotropin-releasing hormone receptor antagonists | |
| IL229320A0 (en) | History of 3-spirocyclic piperidines as ghrelin receptor agonists | |
| EP2765860A4 (en) | Mineralocorticoid receptor antagonists | |
| EP2627329A4 (en) | TRPA1 RECEPTOR ANTAGONIST | |
| EP2697203A4 (en) | ANTAGONISTS OF MINERALOCORTICOID RECEPTORS | |
| HK1210467A1 (en) | Pyrazole compounds as crth2 antagonists crth2 | |
| EP2765859A4 (en) | Mineralocorticoid receptor antagonists | |
| EP2765858A4 (en) | ANTAGONISTS OF A MINERALOCORTICOID RECEPTOR | |
| PT2714647E (pt) | Derivativos bifenil usados como antagonistas do recetor da glicagina | |
| IL232985A0 (en) | Cycloalkane carboxylic acid derivatives as cxcr3 receptor inhibitors | |
| IL230334A0 (en) | Non-competitive nicotinic receptor antagonists | |
| GB201213699D0 (en) | Receptor antagonists II | |
| GB201213698D0 (en) | Receptor antagonists II |